
CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves
The FDA has not decided whether to ask drug manufacturers and retailers like CVS to remove products containing oral phenylephrine from the market.

CVS voluntarily pulling decongestants from shelves that contain ineffective ingredient
CVS Health Corp. CVS, +0.14% is pulling decongestants off their shelves that contain an ingredient an Food and Drug Administration advisory committee determined did not work, according to a Thursda...

CVS Health to remove cold medicine with phenylephrine from shelves - WSJ
CVS Health is pulling some of the most common decongestants with phenylephrine from its shelves and will no longer sell them, after advisers to U.S. health regulators raised doubt over the efficacy...

Final Trades: Mondelez, CVS & more
The "Halftime Report" traders give their top picks to watch for the second half.

CVS, Walgreens and Rite Aid are closing thousands of stores. Here's why
Drug store chains for decades saturated US cities, suburbs and small towns with new stores.

Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
Today's market has changed; there seems to be a divided front between yield and risk. When interest rates are low, it is easy for investors to take on risk in stocks that may be promising some ques...

CVS Stock Rises After Rite Aid Files for Bankruptcy
UnitedHealth earnings last Friday may also be a factor buoying CVS stock.

CVS CFO Shawn Guertin to take leave of absence for family health reasons
CVS Health Corp. CVS, +0.87% said Monday its chief financial officer, Shawn Guertin, is taking a leave of absence due to family health reasons. The drug store chain said Thomas F.

3 Reasons to Buy CVS Health Stock Right Now
CVS Health's brand name carries some weight in the healthcare industry. The company boasts a diversified portfolio of healthcare services.

CVS Health Offers Recession-Resistant Growth With Transformation
CVS Health offers 3.5% Dividend Yield with $14.5 billion in stock repurchase remaining. M&A period is over, now focusing on integrating new businesses and strengthening the balance sheet. Sees cost...

The 3 Top Value Stocks to Watch in Q4 2023
Amid the tumult of a turbulent market landscape, savvy investors cast a hopeful eye toward top value stocks. The Dow is down, shedding over 100 points on Friday, and both the S&P 500 and Nasdaq are...

Here's the Michael Burry Stock That Could Be the Biggest Winner Over the Next 5 Years
Michael Burry is best known for his short positions but is long on nearly 30 stocks. One of his contrarian picks appears to be most likely to succeed because of its attractive valuation and long-te...

CVS Shares Fall Following Pharmacist Walkout Threat at Kansas City Locations
CVS Health (CVS) shares dropped 2.2% on Wednesday after pharmacists at the drugstore chain in Kansas City, Mo. threatened to walk off the job for the second time in a week to protest working condit...

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Fall Covid shot rollout gets off to a bumpy start as some patients see insurance delays
The reports are fueling confusion among insured patients about whether they can still access Covid shots for free — just as cases tick up across the country.
Related Companies